EDUARDO
FERNÁNDEZ-CRUZ PÉREZ
Investigador ata 2016
Publicacións (164) Publicacións de EDUARDO FERNÁNDEZ-CRUZ PÉREZ
2022
-
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
The Lancet Infectious Diseases, Vol. 22, Núm. 5, pp. 622-635
-
Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes
Cellular and Molecular Life Sciences, Vol. 79, Núm. 8
-
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease
Frontiers in Immunology, Vol. 13
-
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
The Lancet, Vol. 399, Núm. 10324, pp. 530-540
-
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
The Lancet Respiratory Medicine, Vol. 10, Núm. 10, pp. 972-984
2021
-
HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients
Frontiers in Immunology, Vol. 12
-
HLA-G in Mayas from Yucatan: An evolutionary approach
International Journal of Immunogenetics, Vol. 48, Núm. 5, pp. 403-408
-
Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain
Clinical and Experimental Immunology, Vol. 203, Núm. 3, pp. 424-432
2019
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963
2018
-
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
Open Forum Infectious Diseases, Vol. 5, Núm. 1
2017
-
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study
Journal of Heart and Lung Transplantation, Vol. 36, Núm. 5, pp. 529-539
-
Impact of the polymorphism rs9264942 near the HLA-C gene on HIV-1 DNA reservoirs in asymptomatic chronically infected patients initiating antiviral therapy
Journal of Immunology Research, Vol. 2017
2016
-
Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial
Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 832-843
-
Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency
Clinical Immunology, Vol. 169, pp. 80-84
-
Peripheral blood T- and B-cell immunophenotypic abnormalities in selected women with unexplained recurrent miscarriage
Journal of Reproductive Immunology, Vol. 113, pp. 50-53
2015
-
Audit of the use of intravenous immunoglobulin for antibody deficiencies in a Clinical Immunology Unit
Allergologia et Immunopathologia
-
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
PLoS ONE, Vol. 10, Núm. 10
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
2014
-
Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion
American Journal of Reproductive Immunology, Vol. 71, Núm. 5, pp. 458-466
2013
-
Alterations of naïve and memory B-cell subsets are associated with risk of rejection and infection in heart recipients
Transplant International, Vol. 26, Núm. 8, pp. 800-812